BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12871077)

  • 1. Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy.
    Güner D; Belka C; Daniel PT
    Curr Med Chem Anticancer Agents; 2003 Sep; 3(5):319-26. PubMed ID: 12871077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death receptor signaling in cancer therapy.
    Fulda S; Debatin KM
    Curr Med Chem Anticancer Agents; 2003 Jul; 3(4):253-62. PubMed ID: 12769771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death on the slopes. Symposium on Cell Death Pathways.
    McPhee CK; Hill JH; Enoksson M
    EMBO Rep; 2009 Aug; 10(8):827-31. PubMed ID: 19609322
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting apoptosis for anticancer therapy.
    Fulda S
    Semin Cancer Biol; 2015 Apr; 31():84-8. PubMed ID: 24859747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic targeting of cell death pathways.
    Mansilla S; Llovera L; Portugal J
    Anticancer Agents Med Chem; 2012 Mar; 12(3):226-38. PubMed ID: 22263795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [p53-regulating pathways as targets for personalized cancer therapy].
    Höpker K; Reinhardt HC
    Dtsch Med Wochenschr; 2013 Jan; 138(3):82-6. PubMed ID: 23299342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies.
    Pistritto G; Trisciuoglio D; Ceci C; Garufi A; D'Orazi G
    Aging (Albany NY); 2016 Apr; 8(4):603-19. PubMed ID: 27019364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy and cancer therapy.
    Kondo Y; Kondo S
    Autophagy; 2006; 2(2):85-90. PubMed ID: 16874083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the Pathways of Resistance to Targeted Therapies.
    Wood KC
    Cancer Res; 2015 Oct; 75(20):4247-51. PubMed ID: 26392071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural products: An upcoming therapeutic approach to cancer.
    Dutta S; Mahalanobish S; Saha S; Ghosh S; Sil PC
    Food Chem Toxicol; 2019 Jun; 128():240-255. PubMed ID: 30991130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to Strike Survival Networks in Cancer.
    Pennati M; Cimino-Reale G; Gatti L; Cassinelli G
    Crit Rev Oncog; 2016; 21(3-4):269-308. PubMed ID: 27915976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting apoptosis pathways in cancer therapy.
    Fulda S; Debatin KM
    Curr Cancer Drug Targets; 2004 Nov; 4(7):569-76. PubMed ID: 15578914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic pathways in tumor progression and therapy.
    Melet A; Song K; Bucur O; Jagani Z; Grassian AR; Khosravi-Far R
    Adv Exp Med Biol; 2008; 615():47-79. PubMed ID: 18437891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 90: a unique chemotherapeutic target.
    Cullinan SB; Whitesell L
    Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD95 signaling in cancer treatment.
    De la Rosa AJ; Gomez MA; Morales S; Padillo FJ; Muntane J
    Curr Pharm Des; 2014; 20(17):2809-18. PubMed ID: 23944368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive Oxygen and Nitrogen Species-Induced Protein Modifications: Implication in Carcinogenesis and Anticancer Therapy.
    Moldogazieva NT; Lutsenko SV; Terentiev AA
    Cancer Res; 2018 Nov; 78(21):6040-6047. PubMed ID: 30327380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.